  See all
 |
Articles: Pharmacoeconomics |
Prior Articles
Accounting for the Development of Antibacterial Resistance in the Cost Effectiveness of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in the UK
PharmacoEconomics, 11/17/09
Weighting Must Wait: Incorporating Equity Concerns into Cost-Effectiveness Analysis May Take Longer than Expected
PharmacoEconomics, 11/17/09 Health costs in patients treated for depression, in patients with depressive symptoms treated for another chronic disorder, and in non-depressed patients: a two-year prospective cohort study in anthroposophic outpatient settings
The European Journal of Health Economics, 11/17/09 Economic Value of Seasonal and Pandemic Influenza Vaccination during Pregnancy
Clinical Infectious Diseases, 11/16/09
Exclusive Author Commentary Societal cost of rheumatoid arthritis patients in the US
Current Medical Research and Opinion, 11/13/09 Economic evaluation of doripenem for the treatment of nosocomial pneumonia in the US: discrete event simulation
Current Medical Research and Opinion, 11/13/09 Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations
Value in Health, 11/11/09 Effect of lean process improvement techniques on a university hospital inpatient pharmacy
American Journal of Health-System Pharmacy, 11/10/09 Economic evaluation of the direct healthcare cost savings resulting from the use of walking interventions to prevent coronary heart disease in Australia
International Journal of Health Care Finance and Economics, 11/09/09 The costs of a sexually transmitted infection outreach and treatment programme targeting most at risk youth in Tajikistan
Cost Effectiveness and Resource Allocation, 11/04/09
Free full text
Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents. A Cost-Effectiveness Analysis
Annals of Internal Medicine, 11/03/09 Cost-effectiveness of interventions based on physical exercise in the treatment of various diseases
International Journal of Technology Assessment in Health Care, 11/02/09 Incidence and economic burden of suspected adverse events and adverse event monitoring during AF therapy
Current Medical Research and Opinion, 10/30/09 Investment in antiviral drugs: a real options approach
Health Economics, 10/29/09 Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: An Industry Perspective: The ISPOR Drug Cost Task Force Report-Part V
Value in Health, 10/29/09 Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: An International Perspective: The ISPOR Drug Cost Task Force Report-Part VI
Value in Health, 10/29/09 Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Managed Care Perspective: The ISPOR Drug Cost Task Force Report-Part III
Value in Health, 10/29/09 The possible macroeconomic impact on the UK of an influenza pandemic
Health Economics, 10/29/09 A simple cost-effective high performance liquid chromatographic assay of sulphadoxine in whole blood spotted on filter paper for field studies
Malaria Journal, 10/27/09
Free full text
Estimating average inpatient and outpatient costs and childhood pneumonia and diarrhoea treatment costs in an urban health centre in Zambia
Cost Effectiveness and Resource Allocation, 10/22/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
153 Available Pages
|
|
